Effects of Low Dose Intrathecal Neostigmine in spinal anesthesia for lower abdominal surgery

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170429033680N6

Enrollment

Registered

2018-02-07

Start date

2016-04-03

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Surgery. Lower abdominal pain, unspecified

Interventions

Intervention 1: Intervention group: Neostigmine 5 µg (0.1 ml) (chemotherapy drug) with 3 ml bupivacaine Hyperbaric (15 mg)(Marcaine_, AstraZeneca, Sweden) and 20 µg fentanyl (0.4 ml)) Chemotherapy Com

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: age between 20-60 years-old Candidate for lower abdominal surgery ASA I,II

Exclusion criteria

Exclusion criteria: Spinal anesthetic contraindication Pregnant mothers

Design outcomes

Primary

Measure	Time frame
PAIN. Timepoint: After operation. Method of measurement: VAS scale.	—

Secondary

Measure	Time frame
Heart beat. Timepoint: during operation. Method of measurement: Heart contraction.;Blood pressure. Timepoint: during operation. Method of measurement: device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Akipour

Mashhad University of Medical Sciences

Alipourm@mums.ac.ir+98 51 3802 2711

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026